Companies live through their people.
- VARIOUS ADVISORY BOARD MANDATES
- INDUSTRIAL HOLDINGS WESTDEUTSCHE LANDESBANK
- AUDIT AUSTRIAN UNILEVER
- BUSINESS GRADUATE
For more than twenty years, we have been investing in companies facing special entrepreneurial challenges, such as first-time market entry, internationalisation, the development of new business fields or corporate succession. Our investment strategy focuses on companies that stand out due to their technological competence and market potential. In the case of companies that are established in the market and striving for a new strategic position, we usually only consider a majority investment, while in the case of young companies that are still in the start-up phase, we usually take minority stakes. We typically invest between 0.5 and 5.0 million Euros.
We have extensive experience in managing and advising larger medium-sized companies and have also have taken part in restructuring, reorganisation, divestments and acquisitions, as well as subsequent corporate integration. On this basis, we support companies in their strategic conception and on concrete implementation issues.
Companies live through their people.
Without trust between all parties involved, sustainable economic success cannot be achieved.
We have established the following steps in order to reach a well-founded and swift decision regarding the investment process.
On the basis of basic information about the industry, business model, size and capital requirements, we clarify whether an investment in your company would generally fit our profile. A personal meeting then reveals whether there is a basis for a trusting and constructive cooperation between all persons involved.
You present your company and we examine it according to economic, financial, technical, organisational and personnel criteria. The aim is to jointly define the entrepreneurial challenges and to develop strategies for expanding competitive advantages and limiting risks.
Owners often evaluate their company differently than investors because the risks associated with the realisation of corporate planning are assessed differently. Open communication about the respective approach to valuation as well as a willingness to compromise help to overcome this hurdle.
Short decision-making processes and legal competence on our side facilitate contract negotiations. Conflict-prone issues should be identified and dealt with at an early stage in the negotiations. This regularly includes the question of when and how participation is to be terminated.
Immediately after conclusion of the contract, we transfer the funds and take over shares as agreed in the contract. While the management of the company remains solely in the hands of its managers, we participate in setting the strategic course on the basis of current reports and analyses. In doing so, we contribute to the entrepreneurial success with our experience and our network.
The time horizon for our investment is not subject to any fixed specifications. However, our investments are not destined for eternity. Therefore, it is also important to find a joint arrangement for a later exit. The primary objective is to provide the company with reliability and security for successful development in the future.
AAICO is a leading AI technology company founded in 2021 by Arya H. Bolurfrushan together with a team of Silicon Valley engineers, applied AI experts and experienced investment professionals. AAICO's team is headquartered in the United Arab Emirates and has global leadership positions in San Francisco, London and Frankfurt. AAICO works on the private equity principle by founding and investing in companies and applying proprietary AI technologies to create measurable value for investors. AAICO directly deploys a combination of capital and AI technology through private and public investments as well as special situations such as the acquisition of distressed AI assets. AAICO targets companies in regulated industries such as insurance, healthcare and financial services that have high document, process and resource needs. Through targeted investments and partnerships with like-minded management teams, AAICO applies its proprietary AI technology to existing business models to deliver measurable margin improvements. It transforms mission-critical problems into scalable products. For example, the DeepDoc product organises and summarises medical records to simplify claims management.
ArtiMinds Robotics GmbH, based in Karlsruhe, offers an integrated software suite for the planning, intuitive graphical programming, operation and optimisation of industrial robot tasks. It is very easy to get started - no additional hardware is required.
ArtiMinds specialises in software products for the intuitive and semi-automatic generation of native robot programs with sensors and complex robot tools. The offering consisting of Robot Programming Suite (RPS) and Learning & Analytics for Robots (LAR) covers the entire workflow from planning, simulation, programming, commissioning, optimisation and monitoring to the reuse of know-how in other projects. Native robot control code is automatically generated that can stream all relevant data for monitoring, analysis and optimisation.
In this way, the commissioning and maintenance effort for sensor-based robot applications can be reduced to a fraction. The savings compared to conventional programming and maintenance can be up to a quarter of the total cost of a turnkey solution if conventional programming were possible. In the case of extremely complicated applications (e.g. previously impracticable sensor-based robotic tasks), it is only ArtiMinds' new approach that enables novel, flexible automation solutions.
ArtiMinds has paying customers in the manufacturing industries of automotive, rail, aerospace, industrial and consumer electronics, general industrial suppliers, cleantech, chemical, pharmaceutical, medical, white goods, home textiles, apparel and food and beverage.
Founded in June 2018 and listed on Nasdaq since July 2021, Atai Life Sciences AG, headquartered in Munich, is a global "biotech company builder" and a platform company that acquires promising compounds and develops them for approval in independent companies. ATAI invests in a variety of compound classes, but prioritises compounds with polypharmacological patterns that affect key biomarkers of mental illness.
ATAI sees significant potential especially in 5HT2A agonists, atypical opioids and agents in the glutamatergic and GABAergic systems. Although psychedelic substances can be found on the ATAI platform, the company does not see itself as a "psychedelics company" but as a mental health innovation platform. The company's vision is to cure mental disorders so that people can lead healthier and happier lives.
Bugshell is a platform that enables customers to easily and transparently assess their company\s IT security. The aim of the penetration tests (pentests for short) offered by bugshell is to check the attack potential of the respective IT infrastructure or application. Vulnerabilities are identified, their risk is assessed and potential chances of success are evaluated in order to recommend appropriate measures to maintain system security.
In carrying out the pentests, the company draws on the know-how and skills of a large number of independent Western European IT software experts who specialise in cyber security. Bugshell can thus tailor the team deployed to the specific set-up and requirements of each customer.
The entire pentest‘s process is displayed on the platform in real time and offers the possibility to react directly to identified vulnerabilities in the IT infrastructure.
Cross Platform Solutions GmbH is a SaaS company that brings transparency to online trading with its transaction intelligence platform under the Grips brand.
Grips visualises online sales of millions of products across all major retailers and analyses the entire sales funnel - from searching on Google to buying a product through online retailers' sites. To do this, Grips categorises the world's largest set of online sales data and processes it using a variety of other information - such as search, traffic and conversion data. On this basis, Grips models product sales in online retail with industry-leading accuracy.
Online retailers and consumer brands can use Grips to understand the market share of brands, products and categories, as well as the distribution of their sales among key market players. This gives them a clear indication of how they can increase their sales - not just the traffic on their websites.
entec is an engineering and general contractor for industrial biogas power plants. It operates worldwide with its companies in Austria, Germany, the United Kingdom and South Africa.
The company is independent of any group and free of manufacturer interests. With more than 40 years of experience of its employees in the waste to energy sector, the company has extensive know-how in the planning, construction, financing, commissioning and operational management of innovative and efficient plants.
Complex large-scale biogas plants were realised in Austria, Germany, Spain, France, Italy as well as India, Korea, Japan, Taiwan, Malawi, South Africa, England and the USA.
With the ECOLINER, a compact, industry-standard biopower plant has also been developed that is based on a containerised design and conceived for low-volume feedstocks from farms, breweries or fruit juice producers.
FMTec GmbH, based in Bludenz/Austria, develops and produces intelligent systems for the protection against theft or access, as well as the localisation of sensitive, valuable or dangerous goods during transport.
The almost 100,000 security containers used by customers every day contain documents and electronic data carriers with secret information (EU-DSGVO), evidence, laboratory samples, patents and development prototypes, money, jewellery, precious metals, medicines, valuable consumer goods (mobile phones, perfumes, tobacco, spirits), as well as expensive measuring instruments and tools.
With the company's products, in addition to increased security, its customers also receive improved error prevention and accelerated processing, and achieve simplification in their processes, with full integration into existing systems.
Founded in 2015, the company has developed capabilities in particular in data sourcing, data aggregation, data analytics (including AI and ML) and data visualisation with its experts from various disciplines of software development. With this set of tools called CAAV (for Crawl, Aggregate, Analyze and Visualise), the company analyses unstructured and structured, private as well as publicly available data sets and enables the benefits to make continuous, data-driven decisions. With the help of experts who master the respective domain-specific concepts (ontologies), Innoplexus can create knowledge graphs for various business areas in which all data are related to each other, whereby the references change with each new date added. Our own developments in blockchain technology allow the secure exchange of results between any actors. More than 100 patents and patent applications in the above-mentioned areas complement the know-how.
On the basis of these core competencies, Innoplexus has developed applications for various business fields. In particular, Innoplexus has become one of the global leaders in the field of AI-based drug research and development and is a sought-after partner of numerous renowned international pharmaceutical companies.
The company has its headquarters in Eschborn, and subsidiaries in the USA and India.
IQ evolution GmbH, based in Aachen, develops and manufactures components with geometrically complex microstructures based on metal 3D printing. The focus is on products that are produced in series and not on prototyping or one-off production.
The focus is on the design of sophisticated liquid coolers with very high cooling performance combined with low weight and volume. These coolers are preferably used in the field of e-mobility and the cooling of power electronics in general.
With its technology, IQ evolution makes it possible to generate ever higher outputs from semiconductor elements, which are usually only limited by insufficient heat dissipation.
QuantaRed Technologies GmbH, based in Vienna/Austria, develops and distributes analytical measuring instruments. The company specialises in the use of quantum cascade lasers (QCL) and their application in the infrared spectroscopy of liquids and gases. It has received relevant patents for this (EU, US).
QuantaRed's EcoSpec® analyser is an outstandingly precise instrument for checking the purity of wastewater in terms of hydrocarbons due to its QCL-based measurement technology. The device also provides technicians and environmental engineers with a powerful tool to detect and quantify oil contamination of soil with an environmentally friendly measurement technique.
The FameSpec® measuring device, which is also based on QCL measurement technology, enables QuantaRed to detect safety-relevant contamination of aircraft fuels. This is relevant as international regulatory requirements for blending biodiesel (fatty acid methyl ester - FAME) into diesel fuel have the side effect of leading to potential FAME cross-contamination of jet fuel in multi-product supply chains.
Founded in 1984 as a specialist for the production of plastic parts for the automotive industry, the company today develops, manufactures and distributes sustainable and innovative medical products. In addition to a high level of usability of the end product and a design suitable for production, the company has set itself the maxim of product development resource conservation and CO2 reduction.
UTK's top product is the BlueLavage®, which is used for pressure irrigation of bone cavities in hip and knee operations. The BlueLavage is a sterile single-use product that does not contain any metal parts and can therefore be completely disposed of as plastic waste. No batteries are needed for its operation. Instead, the BlueLavage® is powered by a compact "Drive Unit" consisting of a motor and the a rechargeable accumulator, which can be recharged up to 150 times.
HCS Beteiligungsgesellschaft mbH located in Frankfurt/Main, Amtsgericht Frankfurt HRB 56689
Management: Hans-Christian Semmler and Renate Semmler
The contents of our pages were created with the greatest care. However, we cannot guarantee that all contents are correct, complete and up-to-date. As a service provider, we are responsible for our own content on these pages in accordance with general laws pursuant to Section 7 (1) of the German Telemedia Act (TMG). However, according to Sections 8 to 10 TMG, we are not obliged as a service provider to monitor transmitted or stored third-party information, or to investigate circumstances that indicate illegal activity. Obligations to remove or block the use of information in accordance with general laws remain unaffected by this. However, liability in this regard is only possible from the point in time at which a concrete infringement of the law becomes known. If we become aware of any such infringements, we will remove the relevant content immediately.
Our website contains links to external websites of third parties over whose content we have no influence. Therefore, we cannot assume any liability for these external contents. The respective provider or operator of the pages is always responsible for the content of the linked pages. The linked pages were checked for possible legal violations at the time of linking. Illegal contents were not recognisable at the time of linking. However, permanent monitoring of the content of the linked pages is not reasonable without concrete indications of an infringement of the law. If we become aware of any infringements of the law, we will remove such links immediately.
The contents and works created by the site operators on these pages are subject to German copyright law. Duplication, processing, distribution and any kind of exploitation outside the limits of copyright require the written consent of the respective author or creator. Downloads and copies of this site are only permitted for private, non-commercial use. Insofar as the content on this site was not created by the operator, the copyrights of third parties are respected. In particular, third-party content is marked as such. Should you nevertheless become aware of a copyright infringement, please inform us accordingly. If we become aware of any infringements, we will remove such content immediately.
Insofar as this website uses Google Analytics, a web analytics service provided by Google, Inc. ("Google"), your browser may store a cookie sent by Google Inc. or third parties that enables an analysis of your use of this website. The information collected (including your IP address) will be transmitted to and stored by Google on servers in the United States. Google will use this information for the purpose of evaluating your use of the website, compiling reports on website activity for website operators and providing other services relating to website activity and internet usage. Google may also transfer this information to third parties where required to do so by law, or where such third parties process the information on Google's behalf. Google will not associate your IP address with any other data held by Google. You can prevent the installation of cookies. To do this, you must select "do not accept cookies" in your browser settings (in Internet Explorer under "Tools / Internet Options / Privacy / Setting", in Firefox under "Tools / Settings / Privacy / Cookies"). Please note that in this case you may not be able to use all the functions of this website to their full extent. By using this website, you consent to the processing of data about you by Google in the manner and for the purposes set out above.
Of course, you can object to the processing of your personal data for advertising and data analysis purposes at any time. You can inform us of your advertising objection using the following contact details: HCS Beteiligungsgesellschaft mbH,
Bockenheimer Landstraße 2-4, D-60306 Frankfurt am Main, Phone.: + 49 (0) 69 264 846 280, Fax: + 49 (0) 69 264 846 281, Email: email@example.com.
The data processed by us will be deleted or restricted in its processing in accordance with Articles 17 and 18 GDPR. Unless expressly stated within the scope of this data protection declaration, the data stored by us will be deleted as soon as it is no longer required for its intended purpose and the deletion does not conflict with any statutory retention obligations. If the data is not deleted because it is required for other and legally permissible purposes, its processing will be restricted. I.e., the data is blocked and not processed for other purposes. This applies, for example, to data that must be retained for reasons of commercial or tax law. According to legal requirements in Germany, data is stored in particular for 6 years in accordance with Art. 257 para. 1 HGB (commercial books, inventories, opening balances, annual financial statements, commercial letters, accounting vouchers, etc.) and for 10 years in accordance with Art. 147 para. 1 AO (books, records, management reports, accounting vouchers, commercial and business letters, documents relevant for taxation, etc.).
If we process data in a third country (i.e., outside the European Union (EU) or the European Economic Area (EEA)) or if this is done in the context of using third-party services or disclosing or transferring data to third parties, this is only done in order to fulfil our (pre-)contractual obligations, on the basis of your consent, due to a legal obligation or on the basis of our legitimate interests. Subject to legal or contractual permissions, we only process or allow the processing of data in a third country if the special requirements of Art. 44 et seq. GDPR are met. This means, for example, that the processing is carried out on the basis of special guarantees, such as the officially recognised determination of a level of data protection corresponding to the EU or compliance with officially recognised special contractual obligations (so-called "standard contractual clauses").